• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Axxam S.p.A.

Axxam is an innovative Partner Research Organization (iPRO). Axxam is a leading provider of integrated discovery services across Life Sciences industries including: pharmaceuticals, crop protection, animal health, cosmetics, fragrances, food and beverages. Axxam is also engaged in alliance-based research towards innovative small molecule therapies for diseases with a high unmet medical need. Axxam's business terms are flexible, ranging from fee-for-service to risk-sharing deal structures. *

 

	Start	2011-07-27 renamed before
	Predecessor	Axxam S.r.l
	Industry	BIOTECH
	Person	Lohmer, Stefan (Axxam 200807 CEO)
	Person 2	Corazza, Sabrina (Axxam 201603 Director Business Development)
	Region	Milano (Milan)
	Country	Italy
	Street	3 Via Meucci OpenZone
	City	20091 Bresso (MI)
	Tel	+39-02-210561
		Address record changed: 2020-12-02
Basic data	Employees	C: 51 to 100 (2016-10-03)
		* Document for �About Section�: Rewind Therapeutics. (1/4/18). "Press Release: Rewind Therapeutics Secures 15.2m Euro to Develop Novel Remyelination Therapies". Leuven.
		Record changed: 2020-11-27

Advertisement

More documents for Axxam S.p.A.

• [1] ERS Genomics Ltd.. (4/2/20). "Press Release: ERS Genomics and Axxam Announce CRISPR/Cas9 License Agreement to Enhance Discovery Services". Dublin & Milan....
• [2] Rewind Therapeutics. (1/4/18). "Press Release: Rewind Therapeutics Secures 15.2m Euro to Develop Novel Remyelination Therapies". Leuven....
• [3] Genedata AG. (9/27/17). "Press Release: Genedata Screener Strengthens Collaborative Research at Axxam". Basel....
• [4] Enamine Ltd.. (8/1/17). "Press Release: Axxam Enters into a Research Collaboration with Enamine for the Enhancement of the Axxam Screening Collection". Milan & Kiev....
• [5] Axxam S.p.A.. (2/1/17). "Press Release: Axxam and Fulcrum Therapeutics Initiate a Partnership for the Provision of Drug Discovery Services for Genetic Diseases"....
• [6] Grünenthal GmbH. (3/3/16). "Press Release: Drug Discovery Collaboration between Grünenthal and Axxam". Aachen & Milano....
• [7] Axxam S.p.A.. (11/19/14). "Press Release: Axxam SpA Enters into Research Collaboration with F. Hoffmann – La Roche Ltd for Assay Development and Screening of Selected Drug Targets". Milan....
• [8] Cellectis S.A.. (1/17/14). "Press Release: Axxam and Cellectis Bioresearch Announce Their Collaboration to Offer a New Generation of Cell Based Assays". Allschwil....
• [9] Lead Discovery Center GmbH. (1/14/14). "Press Release: Hit Discovery Constance GmbH – a New European Hub for HTS and Compound Management". Constance....
• [10] Genedata AG. (12/5/11). "Press Release: Axxam Advances Its High-throughput Screening with Genedata Screener". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.